págs. 539-541
Polycystic liver diseases: from molecular basis to development of effective treatments
págs. 542-545
Factors of easy and difficult cecal intubation during unsedated colonoscopy
Hongxin Chen, Cong Gao, Hongyu Li, Chengkun Li, Chunmei Wang, Zhaohui Bai, Yanyan Wu, Haijuan Yao, Yingchao Li, Fei Gao, Xia-Dong Shao, Xingshun Qi
págs. 546-552
Patricia Latorre, Jorge Torrente Sánchez, Amparo Almudena Pérez Ibañez, José María Tenías Burillo, Nadia Moreno Sánchez, Antonio López Serrano, Eduardo Moreno Osset, Julián Murado Pardo, José María Paredes
págs. 553-558
Long-term clinical outcomes after the discontinuation of anti-TNF agents in patients with inflammatory bowel disease: a meta-analysis
Cong Dai, Yi Nuo Wang, Wen-Ning Tian, Yu Hong Huang, Min Jiang
págs. 559-566
Severe and refractory gastrointestinal toxicity due to immune checkpoint inhibitors: clinical experience in a tertiary referral hospital
Elena Céspedes Martínez, Virginia Robles Alonso, Claudia Herrera de Guise, Luis Mayorga, Francesc Casellas Jordá, María Roca Herrera, Natalia Borruel Sainz
págs. 567-573
págs. 574-575
págs. 576-577
Gastritis severa en paciente tratado con inmunoterapia: ¿inmunomediada o reactivación de citomegalovirus?
Sonia Rebeca Vallejo Rivera, Lidia Nicolás Niza, Lucía Bonilla López, J. Díaz Concepción
págs. 578-579
© 2001-2024 Fundación Dialnet · Todos los derechos reservados